Literature DB >> 20532466

COPD prevalence and the differences between newly and previously diagnosed COPD patients in a spirometry program.

Markos Minas1, Chrisi Hatzoglou, Eleni Karetsi, Andriana I Papaioannou, Kalliopi Tanou, Rita Tsaroucha, Eudoxia Gogou, Konstantinos I Gourgoulianis, Konstantinos Kostikas.   

Abstract

AIMS: To evaluate the prevalence and severity of COPD in a primary care population participating in a spirometry program. Differences between newly and previously diagnosed COPD patients were identified.
METHODS: A spirometry program was conducted in 15 primary care centres. Visitors aged over 30 years who were willing to perform spirometry were included in this program.
RESULTS: A total of 1,526 subjects provided acceptable spirometries. COPD prevalence in our population was 18.4%, of whom 69.0% were newly diagnosed. Most patients were classified as GOLD stages I and II (26.0% and 54.0%, respectively). COPD diagnosis was related to gender (men), age (older subjects), history of repeated respiratory infection in childhood, smoking (>10 pack-years) and presence of symptoms (cough, dyspnoea, wheezing). Variables related to newly diagnosed COPD were younger age and absence of chronic cough.
CONCLUSIONS: A primary care spirometry program may identify a large proportion of undiagnosed COPD patients especially in the early stages of the disease. Newly diagnosed COPD patients were of younger age and presented with less symptoms. These results support the need for spirometry programs in primary care for early COPD detection.

Entities:  

Mesh:

Year:  2010        PMID: 20532466      PMCID: PMC6602262          DOI: 10.4104/pcrj.2010.00034

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  25 in total

1.  Identifying Patients with Undiagnosed COPD in Primary Care Settings: Insight from Screening Tools and Epidemiologic Studies.

Authors:  MeiLan K Han; Anna W Steenrod; Elizabeth D Bacci; Nancy K Leidy; David M Mannino; Byron M Thomashow; R G Barr; Barry J Make; Russ P Bowler; Stephen I Rennard; Julia F Houfek; Barbara P Yawn; Catherine A Meldrum; John W Walsh; Fernando J Martinez
Journal:  Chronic Obstr Pulm Dis       Date:  2015

2.  PLATINO, a nine-year follow-up study of COPD in the city of São Paulo, Brazil: the problem of underdiagnosis.

Authors:  Graciane Laender Moreira; Beatriz Martins Manzano; Mariana Rodrigues Gazzotti; Oliver Augusto Nascimento; Rogelio Perez-Padilla; Ana Maria Baptista Menezes; José Roberto Jardim
Journal:  J Bras Pneumol       Date:  2014 Jan-Feb       Impact factor: 2.624

3.  Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis.

Authors:  Barbara P Yawn; Yunfeng Li; Haijun Tian; Jie Zhang; Steve Arcona; Kristijan H Kahler
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-06-27

4.  Observational study of the outcomes and costs of initiating maintenance therapies in patients with moderate exacerbations of COPD.

Authors:  Anand A Dalal; Manan B Shah; Anna O D'Souza; Orsolya E Lunacsek; Saurabh P Nagar; Glenn D Crater
Journal:  Respir Res       Date:  2012-05-31

5.  Adjusting for COPD severity in database research: developing and validating an algorithm.

Authors:  Lucas M A Goossens; Christine L Baker; Brigitta U Monz; Kelly H Zou; Maureen P M H Rutten-van Mölken
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-12-06

6.  Identifying cases of undiagnosed, clinically significant COPD in primary care: qualitative insight from patients in the target population.

Authors:  Nancy K Leidy; Katherine Kim; Elizabeth D Bacci; Barbara P Yawn; David M Mannino; Byron M Thomashow; R Graham Barr; Stephen I Rennard; Julia F Houfek; Meilan K Han; Catherine A Meldrum; Barry J Make; Russ P Bowler; Anna W Steenrod; Lindsey T Murray; John W Walsh; Fernando Martinez
Journal:  NPJ Prim Care Respir Med       Date:  2015-04-16       Impact factor: 2.871

7.  Sex discrepancies in COPD patients and burden of the disease in females: a nationwide study in Greece (Greek Obstructive Lung Disease Epidemiology and health ecoNomics: GOLDEN study).

Authors:  Andriana I Papaioannou; Eleni Bania; Evangelos C Alexopoulos; Eirini Mitsiki; Foteini Malli; Konstantinos I Gourgoulianis
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-02-17

8.  Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study.

Authors:  Nikolaos Tzanakis; Nikolaos Koulouris; Katerina Dimakou; Konstantinos Gourgoulianis; Epameinondas Kosmas; Georgia Chasapidou; Athanasios Konstantinidis; Christos Kyriakopoulos; Theodoros Kontakiotis; Aggeliki Rapti; Mina Gaga; Konstantinos Kalafatakis; Konstantinos Kostikas
Journal:  BMC Pulm Med       Date:  2021-07-09       Impact factor: 3.317

9.  Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study.

Authors:  Eirini Mitsiki; Eleni Bania; Christos Varounis; Konstantinos I Gourgoulianis; Evangelos C Alexopoulos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-20

Review 10.  Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.

Authors:  Davies Adeloye; Stephen Chua; Chinwei Lee; Catriona Basquill; Angeliki Papana; Evropi Theodoratou; Harish Nair; Danijela Gasevic; Devi Sridhar; Harry Campbell; Kit Yee Chan; Aziz Sheikh; Igor Rudan
Journal:  J Glob Health       Date:  2015-12       Impact factor: 7.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.